Khan M A, Dashwood M R, Thompson C S, Auld J, Morgan R J, Mikhailidis D P
Department of Urology, Royal Free Hospital, Royal Free and University College Medical School, Royal Free Campus, Pond Street, London NW3 2QG, UK.
World J Urol. 1999 Oct;17(5):290-5. doi: 10.1007/s003450050148.
Erectile dysfunction (ED) is a common problem that significantly affects quality of life and psychological well-being. Benign prostatic hyperplasia (BPH) is the commonest known benign proliferative disorder. Recently there has been growing evidence to suggest that patients with high BPH symptom scores have an increased incidence of ED. Endothelin-1 (ET-1) is a potent vasoconstrictor peptide that is thought to play an important role as a modulator of erectile physiology and dysfunction. We investigated whether there were any changes in the penile histology and in the density and distribution of ET-1 and its receptor subtypes in the corpora cavernosa of a rabbit model of partial bladder outflow obstruction (BOO). BOO was induced in 12 adult New Zealand White rabbits; 12 sham-operated rabbits acted as controls. Penises were excised after 3 and 6 weeks (n=6 each for control and BOO). Low- and high-resolution autoradiography was performed using radioligands for ET-1, ET(A) and ET(B) receptors and the results were analysed densitometrically. Ultrastructural evaluation of the corpus cavernosum (CC) was also performed. ET-1, ET(A) and ET(B) receptor-binding sites were primarily localised to the smooth-muscle cells (SMC) of the CC and to the endothelium lining the cavernosal space. ET(B) receptor-binding sites were significantly decreased (P=0.04) in the 6-week BOO cavernosal tissue. These receptor changes were accompanied by ultrastructural changes in the CC. ET-1 may play a role in the pathophysiology of ED associated with BPH. This may partly be due to enhanced vasoconstrictor actions and SMC proliferation secondary to a reduction in ET(B) receptors. Further work is needed to evaluate this possibility.
勃起功能障碍(ED)是一个常见问题,会显著影响生活质量和心理健康。良性前列腺增生(BPH)是最常见的已知良性增生性疾病。最近,越来越多的证据表明,BPH症状评分高的患者ED发病率增加。内皮素-1(ET-1)是一种强效血管收缩肽,被认为在勃起生理和功能障碍的调节中起重要作用。我们研究了部分膀胱流出道梗阻(BOO)兔模型阴茎组织学以及海绵体中ET-1及其受体亚型的密度和分布是否有任何变化。对12只成年新西兰白兔诱导产生BOO;12只假手术兔作为对照。3周和6周后切除阴茎(对照组和BOO组各6只)。使用ET-1、ET(A)和ET(B)受体的放射性配体进行低分辨率和高分辨率放射自显影,并对结果进行密度测定分析。还对海绵体(CC)进行了超微结构评估。ET-1、ET(A)和ET(B)受体结合位点主要定位于CC的平滑肌细胞(SMC)和海绵体腔内衬的内皮。在6周的BOO海绵体组织中,ET(B)受体结合位点显著减少(P = 0.04)。这些受体变化伴随着CC的超微结构变化。ET-1可能在与BPH相关的ED病理生理中起作用。这可能部分是由于ET(B)受体减少继发的血管收缩作用增强和平滑肌细胞增殖。需要进一步开展工作来评估这种可能性。